Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Fund Manager very positive about SNG on latest Vox markets newscast - about 9 mins in
https://youtu.be/6QdeB9B8mtE
Fruits - yes I posted the following article a few weeks ago which highlighted the effort behind writing the RNS from the CEO’s perspective
https://www.conkers3.com/whats-hiding-behind-the-rns/
There has been much discussion today, and recently, over the frequency (or perceived lack) of official communication. I found the following link and view of an ex CEO over what goes on with the construction and timing of an RNS quite insightful.
https://www.conkers3.com/whats-hiding-behind-the-rns/
Very helpful video - have looked at this for a few weeks and now have bought an initial tranche and will look to add....and wait! Thanks to you LTH posters - some very informative posts to help a newbie
https://youtu.be/HoTULGVSEvM
Watch from 18minutes in
Here is a likely effective therapy that has now delivered results in a non hospital setting. It’s welcome news - personally expect SNG P3 and At Home results to be better - however colchicine is a relatively inexpensive therapy. And this is no attempt to deramp - the world needs treatments - as the vaccines have proved there’s room for plenty of suppliers!
Doc - I reckon the Home Trial will be about there on numbers - they don’t need a deluge now (should have done it earlier)....just get the data analyses and out there. If we believe the Saturday post about the RM conversation it was suggested that HT was ‘close’ to filling.....
Doc - I do understand what you’ve been saying about the ‘race’ - however, most of the experts do imply that this will end up as an endemic and also that other coronaviruses will come along, requiring ongoing mitigation with a range of therapies.
I would again highlight the very interesting and relevant interview by Eric Toplol and Prof Eddie Holmes who was involved in the initial sequencing of COVID 19. One of his later comments in the interview highlights the need to develop and stockpile anti-virals that can fight a broad spectrum of viruses. The ongoing market will be significant. I know that it’s already been posted but worth putting up here again.
https://www.medscape.com/viewarticle/943251
Kenneth - I know someone has pushed the Lancet review your way - it is also worth searching for poster CW25’s experience once he got his parents (both in their 70s I recall) on the trial. Their experience of the trial was very good - he said that the daily monitoring that went on with the nursing team provided a huge amount of reassurance to them
Coming from the BMJ this is a pretty worrying read - it’s what not has been disclosed to the regulators or sought by them....vaccines are a must but decisions are seemingly being made without questioning certain key aspects. And protective assumptions are being made that perhaps will not hold water....are we storing up massive problems further down the line. Doshi raises a number of seemingly valid concerns and the demand for greater transparency seems entirely reasonable and justified!